PROMIS NEUROSCIENCES INC. Increase (Decrease) in Prepaid Expense and Other Assets
PROMIS NEUROSCIENCES INC. (PMN) reported Increase (Decrease) in Prepaid Expense and Other Assets of $231.12 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-13
- PROMIS NEUROSCIENCES INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$300.24K.
- PROMIS NEUROSCIENCES INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $531.36K.
- PROMIS NEUROSCIENCES INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$2.99M, a 195.16% decline year-over-year.
- PROMIS NEUROSCIENCES INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $1.06M, a 48.48% decline year-over-year.
- PROMIS NEUROSCIENCES INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$2.56M, a 155.56% decline from fiscal 2024.
- PROMIS NEUROSCIENCES INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $4.60M, a 2354.93% increase from fiscal 2023.
- PROMIS NEUROSCIENCES INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $187.32K, a 41.23% decline from fiscal 2022.
- PROMIS NEUROSCIENCES INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $318.75K, a 46.93% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$300.24K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $231.12K 10-Q · filed 2026-08-13 | -$2.76M derived: sum of 3 quarters · filed 2026-08-13 | -$1.70M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $531.36K 10-Q · filed 2026-05-12 | -$2.46M derived: sum of 2 quarters · filed 2026-05-12 | -$1.40M derived: sum of 3 quarters · filed 2026-05-12 | -$1.69M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | -$2.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$1.93M derived: sum of 2 quarters · filed 2026-03-25 | -$2.22M derived: sum of 3 quarters · filed 2026-08-13 | -$2.56M 10-K · filed 2026-03-25 |
| 2025-09-30 | $1.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $776.61K derived: sum of 2 quarters · filed 2026-08-13 | $438.69K 10-Q · filed 2025-11-12 | $3.58M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$282.99K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$620.91K 10-Q · filed 2026-08-13 | $2.53M derived: sum of 3 quarters · filed 2026-08-13 | $4.58M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$337.92K 10-Q · filed 2026-05-12 | $2.81M derived: sum of 2 quarters · filed 2026-05-12 | $4.86M derived: sum of 3 quarters · filed 2026-05-12 | $4.23M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $3.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $5.20M derived: sum of 2 quarters · filed 2026-03-25 | $4.57M derived: sum of 3 quarters · filed 2026-03-25 | $4.60M 10-K · filed 2026-03-25 |
| 2024-09-30 | $2.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.42M derived: sum of 2 quarters · filed 2025-11-12 | $1.45M 10-Q · filed 2025-11-12 | $1.68M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$634.19K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$603.87K 10-Q · filed 2025-08-13 | -$377.65K derived: sum of 3 quarters · filed 2025-08-13 | $364.81K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $30.33K 10-Q · filed 2025-05-12 | $256.55K derived: sum of 2 quarters · filed 2025-05-12 | $999.00K derived: sum of 3 quarters · filed 2025-05-12 | $171.68K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $226.22K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $968.68K derived: sum of 2 quarters · filed 2025-03-31 | $141.35K derived: sum of 3 quarters · filed 2025-03-31 | $187.32K 10-K · filed 2025-03-31 |
| 2023-09-30 | $742.46K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$84.86K derived: sum of 2 quarters · filed 2024-11-14 | -$38.90K 10-Q · filed 2024-11-14 | -$501.83K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | -$827.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$781.36K 10-Q · filed 2024-08-08 | -$1.24M derived: sum of 3 quarters · filed 2024-08-08 | -$968.80K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $45.97K 10-Q · filed 2024-05-14 | -$416.97K derived: sum of 2 quarters · filed 2024-05-14 | -$141.48K derived: sum of 3 quarters · filed 2024-05-14 | $487.62K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | -$462.94K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$187.45K derived: sum of 2 quarters · filed 2024-04-01 | $441.65K derived: sum of 3 quarters · filed 2024-04-01 | $318.75K 10-K · filed 2024-04-01 |
| 2022-09-30 | $275.49K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $904.59K derived: sum of 2 quarters · filed 2023-11-14 | $781.68K 10-Q · filed 2023-11-14 | -$521.42K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $629.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $506.19K 10-Q · filed 2023-08-14 | -$796.91K derived: sum of 3 quarters · filed 2023-08-14 | $643.70K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$122.91K 10-Q · filed 2023-05-15 | -$1.43M derived: sum of 2 quarters · filed 2023-05-15 | $14.60K derived: sum of 3 quarters · filed 2023-05-15 | |
| 2021-12-31 | -$1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $137.51K derived: sum of 2 quarters · filed 2023-03-08 | $600.63K 10-K · filed 2023-03-08 | |
| 2021-09-30 | $1.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $1.90M 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $463.13K 10-Q · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |